Precigen (PGEN) Assets Average (2013 - 2026)
Precigen (PGEN) reported Assets Average of $147.1 million for Q1 2026, up 7.33% year-over-year from $137.0 million in Q1 2025, and down 9.99% quarter-over-quarter from $163.4 million in Q4 2025.
Precigen (PGEN) Assets Average (2013 - 2026) Analysis & Trends
Precigen (PGEN) has 14 years of Assets Average data on file, last reported at $147.1 million in Q1 2026.
- Assets Average for Q1 2026 came in at $147.1 million, up 7.33% year-over-year; the trailing twelve-month figure through Mar 2026 was $147.1 million (up 7.33% YoY), and the FY2025 annual result was $150.4 million, up 1.51% from the prior year.
- Assets Average eased to $147.1 million in Q1 2026 per PGEN's latest filing, from $163.4 million in the prior quarter.
- Over five years, Assets Average peaked at $347.7 million in Q1 2022 and troughed at $78.3 million in Q3 2024.
- A 5-year average of $186.3 million and a median of $163.4 million in 2025 frame the typical range for Assets Average.
- The sharpest annual moves came in 2024 and 2025: Assets Average tumbled 60.67% in 2024, then surged 74.39% in 2025.
- A 5-year view of Assets Average shows it stood at $237.6 million in 2022, then retreated by 28.09% to $170.9 million in 2023, then slumped by 33.06% to $114.4 million in 2024, then jumped by 42.86% to $163.4 million in 2025, then declined by 9.99% to $147.1 million in 2026.
- Business Quant data shows PGEN's Assets Average at $147.1 million in Q1 2026, $163.4 million in Q4 2025, and $136.6 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Assets Avg. (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 719,706.53 Bn | 719,706.50 Bn | - | 33.42 Mn |
| 2 | Belite Bio | 55,800.00 Bn | 55,800.00 Bn | - | 795.91 Mn |
| 3 | Quantum Biopharma | 18,182.30 Bn | 18,182.29 Bn | - | 13.04 Mn |
| 4 | Legend Biotech | 3,154.00 Bn | 3,153.71 Bn | 242.10 Mn | 1.72 Bn |
| 5 | Akari Therapeutics | 1,844.30 Bn | 1,844.29 Bn | - | 40.89 Mn |
| 6 | Evaxion A | 1,567.96 Bn | 1,567.94 Bn | - | 26.03 Mn |
| 7 | Psyence Biomedical | 251.43 Bn | 251.42 Bn | - | 10.06 Mn |
| 8 | Vertex Pharmaceuticals | 112.56 Bn | 105.31 Bn | 2.59 Bn | 26.06 Bn |
| 9 | Abivax | 94.37 Bn | 94.37 Bn | - | 660.38 Mn |
| 10 | Precigen | 1.27 Bn | 1.27 Bn | 20.69 Mn | 147.07 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 147.07 Mn |
| Dec 31, 2025 | 163.38 Mn |
| Sep 30, 2025 | 136.58 Mn |
| Jun 30, 2025 | 115.34 Mn |
| Mar 31, 2025 | 137.03 Mn |
| Dec 31, 2024 | 114.37 Mn |
| Sep 30, 2024 | 78.32 Mn |
| Jun 30, 2024 | 104.00 Mn |
| Mar 31, 2024 | 142.95 Mn |
| Dec 31, 2023 | 170.87 Mn |
| Sep 30, 2023 | 199.11 Mn |
| Jun 30, 2023 | 224.54 Mn |
| Mar 31, 2023 | 228.76 Mn |
| Dec 31, 2022 | 237.61 Mn |
| Sep 30, 2022 | 290.23 Mn |
| Jun 30, 2022 | 328.40 Mn |
| Mar 31, 2022 | 347.71 Mn |
| Dec 31, 2021 | 368.38 Mn |
| Sep 30, 2021 | 389.74 Mn |
| Jun 30, 2021 | 404.78 Mn |